Company Filing History:
Years Active: 1980-1981
Title: Douwe J. Van Linge: Innovator in Pharmaceutical Compositions
Introduction
Douwe J. Van Linge, an accomplished inventor based in Eemnes, Netherlands, has made significant contributions to the field of pharmaceuticals. With a total of two patents to his name, his work primarily focuses on creating effective solvent vehicles for therapeutics.
Latest Patents
Van Linge's latest patents detail innovative pharmaceutical compositions that enable the effective parenteral administration of therapeutics. His inventions relate to a solvent vehicle for therapeutics, comprised of a dialkyl ester of adipic acid and optionally DMSO. This formulation is particularly advantageous for therapeutic materials with low solubility or those insoluble in water. The compositions he has developed are designed for intramuscular injection, allowing for improved treatment options for diseases caused by internal parasites, including liver fluke disease. A notable embodiment of his invention includes an injectable composition that uses specific compounds and DMSO for enhanced efficacy.
Career Highlights
Douwe J. Van Linge has established a commendable career at Acf Chemiefarma N.V., a company recognized for its contributions to the pharmaceutical industry. His work focuses on developing innovative solutions that address key challenges in drug solubility and delivery, reflecting his commitment to improving therapeutic applications.
Collaborations
Throughout his career, Van Linge has collaborated with esteemed colleagues, including Cornelis A. Ladage and Huibert A. Van Riessen. These collaborations have likely contributed to the advancement of his research and the successful development of his patented pharmaceutical compositions.
Conclusion
Douwe J. Van Linge's work stands as a testament to the importance of innovation in the pharmaceutical sector. His patented inventions not only enhance drug delivery methods but also pave the way for more effective treatments against diseases resulting from internal parasites. As he continues to push the boundaries of pharmaceutical development, Van Linge exemplifies the spirit of innovation within the industry.